How Much Does Testosterone Enanthate Cost in Mississippi in 2026?

Mississippi Retail Cash Prices: What You Will Actually Pay

The average cash-pay price for testosterone enanthate across Mississippi retail pharmacies in 2026 sits at roughly $70 per month for a standard 200 mg/mL vial. That is well below the manufacturer list price of $120 per month, and the gap exists because generic testosterone enanthate has been available for decades. Pricing varies by pharmacy chain and location.

Walmart, CVS, and Walgreens locations in Jackson, Gulfport, and Hattiesburg typically charge between $55 and $90 for a 1 mL vial of 200 mg/mL testosterone enanthate without insurance. Independent pharmacies in smaller cities like Tupelo, Meridian, and Southaven may price slightly higher due to lower purchasing volume, though a few run loyalty programs that drop the cost to the $50 range.

The T-Trials, a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine (N=790 men aged 65 and older), confirmed that testosterone treatment raised serum levels to the mid-normal range and improved sexual function, physical activity, and mood over 12 months 1. These findings helped standardize the clinical rationale that now supports insurance and telehealth prescribing of testosterone enanthate nationwide, including Mississippi.

Discount programs from GoodRx, RxSaver, and SingleCare can reduce the out-of-pocket retail price by 20% to 50%, depending on which pharmacy accepts the coupon. A GoodRx coupon at a Kroger pharmacy in Flowood, for example, may bring a 1 mL vial below $40. These coupons cannot be combined with insurance, so they work best for uninsured or underinsured patients.

Mississippi Medicaid: Why Coverage Is Denied and What to Do Instead

Mississippi Medicaid does not cover testosterone enanthate for male hypogonadism. This applies to both the brand-name Delatestryl formulation and all generic equivalents. The exclusion is part of Mississippi's broader formulary restrictions on hormonal therapies that the state considers non-essential.

The denial is categorical. Submitting a prior authorization request for testosterone enanthate through Mississippi Medicaid will result in rejection regardless of clinical documentation. This affects an estimated 720,000 adult Medicaid enrollees in the state, according to 2025 data from the Centers for Medicare & Medicaid Services.

For Medicaid patients with confirmed hypogonadism (total testosterone consistently below 300 ng/dL on two morning draws), the practical options are: pay cash at the retail average of $70 per month, use a discount coupon to reduce that further, or explore compounded testosterone enanthate from a licensed 503A pharmacy at approximately $80 per month. Some men on Medicaid qualify for manufacturer patient-assistance programs, though testosterone enanthate's generic status makes these less common than for newer branded therapies.

The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic androgen deficiency confirmed by reliable assays, and specifies that testosterone enanthate 75 to 100 mg weekly (or 150 to 200 mg every two weeks) is a first-line intramuscular option 2. Mississippi Medicaid's exclusion is a coverage decision, not a clinical one.

Insurance Coverage Across Mississippi Commercial Plans

Most commercial insurance plans operating in Mississippi will cover testosterone enanthate with a confirmed diagnosis and prior authorization. Blue Cross Blue Shield of Mississippi, Ambetter (Magnolia Health), United Healthcare, Cigna, and Aetna all include generic testosterone enanthate on their formularies, though tier placement and copay levels differ.

BCBS of Mississippi typically places testosterone enanthate on Tier 2 (preferred generic), resulting in copays of $10 to $25 per fill. Ambetter and United Healthcare plans sold through the Mississippi Health Insurance Marketplace generally assign it to Tier 2 or Tier 3, with copays ranging from $15 to $45.

Prior authorization requirements are standard. Insurers in Mississippi require at least two serum total testosterone levels below 300 ng/dL, drawn between 7:00 AM and 10:00 AM, plus documented symptoms of hypogonadism. The American Urological Association's 2018 guideline reinforces this diagnostic threshold and recommends against testosterone therapy in men planning fertility in the near term, since exogenous testosterone suppresses spermatogenesis 3.

If your insurer denies coverage, request a peer-to-peer review. In Mississippi, state insurance regulations (Mississippi Code § 83-41-403) require insurers to offer an external review process for denied claims. Many initial denials are overturned when the prescribing clinician speaks directly with the plan's medical director and provides lab documentation.

Compounded Testosterone Enanthate in Mississippi: Legal Status and Pricing

Compounded testosterone enanthate is legal in Mississippi through licensed 503A compounding pharmacies. These pharmacies operate under a valid prescription for an individual patient, as permitted by Section 503A of the Federal Food, Drug, and Cosmetic Act and regulated at the state level by the Mississippi Board of Pharmacy.

The average price for compounded testosterone enanthate in Mississippi is $80 per month. That is slightly higher than the retail generic average of $70, which may seem counterintuitive. The price difference reflects the smaller batch sizes and higher per-unit compounding costs at 503A pharmacies compared to large-scale generic manufacturers.

Why would a patient choose compounded over commercial generic? Three common reasons. First, compounding pharmacies can prepare testosterone enanthate in sesame oil, cottonseed oil, or grape seed oil carriers, accommodating patients with specific oil allergies. Second, compounders can adjust concentration (e.g., 250 mg/mL instead of the standard 200 mg/mL) to reduce injection volume. Third, some patients prefer the perceived quality control of a local compounding pharmacy.

The FDA has raised concerns about compounded sterile injectables, particularly from 503B outsourcing facilities. A 2023 FDA safety communication emphasized that compounded drugs are not FDA-approved and may carry higher contamination risk than commercially manufactured products. Mississippi patients using compounded testosterone should verify that their pharmacy holds a current Mississippi Board of Pharmacy compounding license and follows USP 797 sterile compounding standards.

Telehealth TRT in Mississippi: How It Works and What It Costs

Telehealth prescribing of testosterone enanthate is legal in Mississippi. The Mississippi State Board of Medical Licensure permits physicians and advanced practice providers to prescribe controlled substances, including Schedule III testosterone, via telehealth after establishing a valid patient-provider relationship through a synchronous audio-video visit.

Several national telehealth TRT platforms operate in Mississippi, including HealthRX, Hone Health, and Vault Health. Pricing models vary. Subscription-based services typically charge $100 to $199 per month, bundling the consultation, lab work, medication, and supplies. The medication itself within these bundles is usually compounded testosterone enanthate or cypionate sourced from a partnered 503A or 503B pharmacy.

For patients who prefer to use their local Mississippi pharmacy, a telehealth clinician can send a prescription to any in-state retail pharmacy. The patient then pays the retail cash price (averaging $70) or uses their insurance. This approach separates the consultation fee (typically $75 to $150 for the initial visit, $50 to $75 for follow-ups) from the medication cost.

Mississippi law requires that the prescribing provider review lab work before initiating testosterone therapy. At minimum, this includes a comprehensive metabolic panel, complete blood count with hematocrit, total and free testosterone, LH, FSH, and PSA for men over 40. The Endocrine Society guideline recommends monitoring hematocrit at 3 to 6 months after starting therapy, then annually, maintaining it below 54% to reduce polycythemia-related cardiovascular risk 2.

A 2010 meta-analysis of 51 randomized controlled trials (N=3,431 men) published in BMC Medicine found that testosterone therapy was associated with a significant increase in hemoglobin and hematocrit, reinforcing the importance of regular blood monitoring during treatment 4.

Price Comparison: Mississippi vs. Neighboring States

Mississippi's average cash-pay price of $70 per month for testosterone enanthate is competitive within the Southeast. Alabama averages $68, Louisiana $75, Tennessee $72, and Arkansas $65. Prices in Mississippi track closely to the regional median, reflecting similar pharmacy benefit manager contracts and wholesale acquisition costs across these states.

The meaningful cost variable between states is not the drug price itself. It is insurance coverage. Mississippi's Medicaid exclusion stands in contrast to Tennessee's TennCare program, which covers testosterone enanthate for documented hypogonadism with prior authorization. Louisiana Medicaid also covers it under restricted criteria. Men near the Mississippi-Tennessee border (DeSoto County, for instance) cannot use out-of-state Medicaid benefits, but those with commercial insurance that operates across state lines will see no pricing difference based on which state's pharmacy fills the prescription.

For uninsured Mississippi residents, the most cost-effective strategy is to combine a GoodRx or SingleCare discount coupon with a high-volume pharmacy like Costco (membership not required for pharmacy use in Mississippi) or Walmart. Costco pharmacies in Mississippi have historically offered some of the lowest testosterone enanthate cash prices in the state, often $30 to $45 per vial.

How to Reduce Your Testosterone Enanthate Cost in Mississippi

Start with your insurance formulary. If testosterone enanthate is covered on Tier 2, your copay may be lower than any discount program. Call the number on the back of your insurance card and ask specifically whether testosterone enanthate 200 mg/mL injection is on formulary and what prior authorization criteria apply.

If you are uninsured or your plan excludes testosterone enanthate, use a pharmacy discount tool. GoodRx, RxSaver, and SingleCare all operate in Mississippi and are accepted at most chain pharmacies. Compare prices across at least three pharmacies before filling. Prices can differ by $30 or more between two pharmacies in the same zip code.

Consider a 90-day fill. Some pharmacies offer a lower per-unit cost on a 5 mL or 10 mL multi-dose vial compared to individual 1 mL vials. A 10 mL vial of testosterone enanthate 200 mg/mL contains approximately 10 weeks of supply at 200 mg per week, and the cash price for a 10 mL vial typically ranges from $80 to $150, significantly less per dose than buying single vials monthly.

Ask your prescriber about testosterone cypionate as a therapeutic equivalent. Testosterone cypionate has an identical clinical profile, the same FDA-approved indications, and is sometimes $5 to $15 cheaper per vial in Mississippi due to differences in generic manufacturer pricing. The pharmacokinetic profiles of enanthate and cypionate are so similar that the Endocrine Society guideline treats them as interchangeable 2.

Safety Monitoring and Ongoing Costs Beyond the Medication

The drug cost is only part of the total expense. Testosterone enanthate therapy requires baseline and follow-up lab work, which adds $100 to $300 per panel without insurance. Standard monitoring includes total testosterone (trough level, drawn the morning before the next injection), hematocrit, PSA, and a lipid panel.

The Endocrine Society recommends checking testosterone levels and hematocrit at 3 months, 6 months, and then every 6 to 12 months on stable therapy 2. A complete monitoring panel at a Quest Diagnostics or Labcorp location in Mississippi typically costs $80 to $150 with a self-pay discount, or $15 to $45 as an insurance copay.

Injection supplies add another $5 to $15 per month. A standard intramuscular injection requires a drawing needle (18-gauge), an injecting needle (22 to 25-gauge, 1 to 1.5 inch), a 3 mL syringe, and an alcohol swab. Amazon and medical supply sites sell these in bulk for less than pharmacy retail pricing.

The TRAVERSE trial (N=5,246 men aged 45 to 80 with hypogonadism and cardiovascular risk factors), published in the New England Journal of Medicine in 2023, found that testosterone replacement therapy did not increase the incidence of major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months 5. This trial provides the strongest safety evidence to date for cardiovascular outcomes in men on TRT, though it did observe a higher incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group. Regular monitoring catches early signals of these complications.

Dr. Shalender Bhasin, principal investigator of the TRAVERSE trial, stated: "These results should provide reassurance that testosterone therapy, when prescribed for men with hypogonadism, does not increase the risk of heart attack or stroke" 5.

The American Urological Association's guideline panel wrote: "Clinicians should inform testosterone deficient patients that low testosterone is a risk factor for cardiovascular disease" 3. This framing positions treatment not merely as symptom relief but as a component of broader cardiometabolic risk management in appropriately selected men.

Hematocrit above 54% on testosterone therapy requires dose reduction or temporary cessation and possible therapeutic phlebotomy. Mississippi Blood Services and Vitalant both accept therapeutic phlebotomy donations at no charge to the patient, though scheduling availability varies by location.